To validate the tumour‐suppressive role of FOXO3 in pancreatic cancer, we conducted gain‐of‐function experiments, the results of which suggested that FOXO3 overexpression could suppress the proliferation of pancreatic cancer cells alongside inducing their apoptosis. This evidence concerns the gene FOXO3 and familial pancreatic carcinoma.